Restoration by aspirin of impaired plasma maspin level in human breast cancer

References

• Jenkins DC, Charles LG, Thomsen LL, Moss LJ, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392–6
   PubMed Web of Science ®Google Scholar
• Dong Z, Qi X, Xie K, Fidler IJ. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharides-responsive and lipopolysaccharides-nonresponsive murine macrophages. J Immunol 1993; 151: 2717–24
   PubMed Web of Science ®Google Scholar
• Uchida T, Yamashita T, Araki A, Watanabe H, Sendo F. rIFN-gamma-activated rat neutrophils induce tumor cell apoptosis by nitric oxide. Int J Cancer 1997; 71: 231–6
   PubMedGoogle Scholar
• Sinha AK, Acharya K, Bhattacharya S, Patra SC, Guha M, Ray U, et al. Neutralization by “antineoplastin” of insulin-activated nitric oxide synthase antibody and its effects in cancer. J Cancer Res Clin Oncol 2002; 128: 659–68
   PubMedGoogle Scholar
• Khalkhali-Ellis Z, Hendrix MJ. Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 2003; 162: 1411–7
   PubMedGoogle Scholar
• Zou Z, Anisowicz A, Hendrix M, Thor A, Neveu M, Sheng S, et al. Maspin, a serpin with tumor – suppressing activity in human mammary epithelial cells. Science 1994; 263: 526–9
   PubMed Web of Science ®Google Scholar
• Ngamkitidechakul C, Warejcka DJ, Burke JM, O'Brien WJ, Twining SS. Maspin: Synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. J Biol Chem 2003; 278: 31796–806
   PubMedGoogle Scholar
• Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol 2001; 195: 321–6
   PubMedGoogle Scholar
• Hojo T, Akiyama Y, Nagasaki K, Maruyama K, Kikuchi K, Ikeda T, et al. Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett 2001; 171: 103–10
   PubMedGoogle Scholar
• Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D, et al. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 2001; 61: 6945–51
   PubMedGoogle Scholar
• Li Z, Shi HY, Zhang M. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 2005; 24: 2008–19
   PubMed Web of Science ®Google Scholar
• Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets 2003; 14: 421–7
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996; 380: 221–6
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Chakraborty Patra S, BasuRoy S, Khan NN, Sinha AK. Purification and properties of insulin-activated nitric oxide synthase from human erythrocyte membranes. Arch Physiol Biochem 2001; 109: 441–9
   PubMedGoogle Scholar
• Zafiriou OC, McFarland M. Determination of trace levels of nitric oxide in aqueous solution. Anal Chem 1980; 52: 1662–7
   Web of Science ®Google Scholar
• Maruf A, Biswas MHU, Rahman MM, AlamBhuiyan MS, MostofaKamal M, Sadik G. Development of a spectrophotometric method for the determination of aspirin in blood sample. The Sciences 2001; 1: 61–2
   Google Scholar
• TlaskalovaHogenova H, Stepankova R. Development of antibody formation in germ free and conventionally reared rabbits: The role of intestinal lymphoid tissue in antibody formation to E. coli. Folia Biol (Praha) 1980; 26: 81–93
   PubMedGoogle Scholar
• Engvall E, Perlmann P. Enzyme-linked immunosorbant assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972; 109: 129–35
   PubMed Web of Science ®Google Scholar
• Steering Committee of the Physicians’ Health study research group. Final report on the aspirin component of the aspirin component of the ongoing physicians health study. N Engl J Med 1989;32:129.
   Google Scholar
• Swede H, Mirand AL, Menezes RJ, Moysich KB. Association of regular aspirin use and breast cancer risk. Oncology 2005; 68: 40–7
   PubMedGoogle Scholar
• Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, et al. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 261–4
   PubMed Web of Science ®Google Scholar